erythromycin propionate-n-acetylcysteinate has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hoy, JJ; Iglesias-Bartolome, R; Kuhn, S; Park, J; Salinas Parra, N | 1 |
1 other study(ies) available for erythromycin propionate-n-acetylcysteinate and Prostatic Neoplasms
Article | Year |
---|---|
Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth.
Topics: Acetylcysteine; Animals; Cell Line, Tumor; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Erythromycin; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Female; GTP-Binding Protein alpha Subunits; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Prostatic Neoplasms | 2020 |